EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 57 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $363,091 | +50611.0% | 404,820 | -33.3% | 0.00% | – |
| Q4 2022 | $716 | -100.0% | 606,488 | -8.4% | 0.00% | -100.0% |
| Q3 2022 | $4,988,000 | +47.3% | 662,369 | +23.2% | 0.00% | +100.0% |
| Q2 2022 | $3,387,000 | +5.2% | 537,615 | +38.6% | 0.00% | 0.0% |
| Q1 2022 | $3,221,000 | +117.2% | 387,791 | +35.8% | 0.00% | – |
| Q4 2021 | $1,483,000 | +5.3% | 285,638 | +35.4% | 0.00% | – |
| Q3 2021 | $1,409,000 | -11.9% | 210,933 | +12.4% | 0.00% | -100.0% |
| Q2 2021 | $1,599,000 | +9.8% | 187,669 | +13.9% | 0.00% | – |
| Q1 2021 | $1,456,000 | +9.5% | 164,740 | +52.2% | 0.00% | – |
| Q4 2020 | $1,330,000 | +66.7% | 108,210 | +10.4% | 0.00% | – |
| Q3 2020 | $798,000 | -15.2% | 97,981 | 0.0% | 0.00% | – |
| Q2 2020 | $941,000 | +81.3% | 97,981 | +28.4% | 0.00% | – |
| Q1 2020 | $519,000 | +22.4% | 76,296 | +167.8% | 0.00% | – |
| Q4 2019 | $424,000 | +122.0% | 28,488 | +52.7% | 0.00% | – |
| Q3 2019 | $191,000 | -3.5% | 18,653 | +0.1% | 0.00% | – |
| Q2 2019 | $198,000 | -24.1% | 18,635 | 0.0% | 0.00% | – |
| Q1 2019 | $261,000 | -30.0% | 18,635 | -49.3% | 0.00% | – |
| Q4 2018 | $373,000 | +92.3% | 36,750 | +127.9% | 0.00% | – |
| Q3 2018 | $194,000 | – | 16,125 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |